Search clinical trials for: hepatitis C

Total 490898 results

Assiut University

Unknown

Pathology of Hepatitis c Nephropathy

Cryoglobulinaemia Due to Chronic Hepatitis C

Egypt
Intermountain Health Care, Inc.

Withdrawn

Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors (TPEGHCVS)

Chronic Hepatitis C Virus Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age

Hepatitis B

Thailand
Humanity and Health Research Centre
Beijing 302 Hospital

Completed

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients

Chronic Hepatitis C Infection

China
Humanity and Health Research Centre
Beijing 302 Hospital

Completed

SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients

Chronic Hepatitis C Infection

China
Humanity and Health Research Centre
Beijing 302 Hospital

Completed

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients

Chronic Hepatitis C Infection

China
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Hepatitis B | Measles | Pertussis | Rubella | Mumps | Tetanus | Diphtheria | Varicella | Poliomyelitis | Haemophilus Infections

Germany, Italy
Kaohsiung Medical University Chung-Ho Memorial...
National Taiwan University Hospital

Completed

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy (BOLERO-CB)

Hepatitis C, Chronic

Taiwan
Sunshine Lake Pharma Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects

Chronic Hepatitis c

China
King Abdullah International Medical Research Center
Hoffmann-La Roche

Unknown

To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B (RC14/055)

Hepatitis B

Saudi Arabia
Kawin Technology Share-holding Co., Ltd.
KawinGreen Biotech Co., Ltd.

Completed

Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C (SOF_GT2)

Hepatitis C, Chronic | Hepatitis C Virus Infection, Response to Therapy of

China
Assiut University

Unknown

The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver Cirrhosis

Hepatitis C
Sakarya University

Unknown

Incidence Of Hepatitis In Intensive Care Unit

Intensive Care Unit

Turkey
Enyo Pharma
PRA Health Sciences

Completed

EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B, Chronic

Netherlands
GlaxoSmithKline

Withdrawn

Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel

Hepatitis A
Hoffmann-La Roche

Completed

An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C

Hepatitis C, Chronic

Germany
Wen-hong Zhang

Unknown

Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients

Chronic Hepatitis b

China
Hannover Medical School

Terminated

Pharmacovigilance in Gerontopsychiatric Patients (GAP)

Depression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic Disorders

Germany
KEMRI-Wellcome Trust Collaborative Research Program
University of Colorado, Denver; GlaxoSmithKline; University of Oxford; Kenya Ministry...

Unknown

PCV10 Reactogenicity and Immunogenicity Study - Malindi (PRISM)

Pneumococcal Pneumonia

Kenya
Eisai Inc.

Completed

Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501

Thrombocytopenia

United States
AbbVie

Completed

A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection

Chronic Hepatitis C | Hepatitis C Virus
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection

Chronic HCV Infection

China, Hong Kong, Taiwan, Korea, Republic of, Vietnam
Asan Medical Center
Samsung Medical Center; Seoul National University Hospital; Korea University... and other collaborators

Completed

Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B (IN-US-0205)

Chronic Viral Hepatitis B Without Delta-agent

Korea, Republic of
Zhongshan Hospital Xiamen University

Unknown

Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis

Cirrhosis, Liver

China
Southwest Hospital, China

Unknown

Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China

Hepatopulmonary Syndrome

China
University Hospital, Toulouse
MSD France

Completed

Retrospective Efficacy and Safety Study With Elbasvir/Grazoprevir in HCV-infected Patients With Chronic Kidney Disease

Chronic Kidney Diseases | Hepatitis C

France
Haukeland University Hospital
University of Bergen

Unknown

Liver Elastography in Patients Undergoing Treatment for Hepatitis C

Hepatitis C Virus Infection

Norway
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
University of Florence

Unknown

Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropathy (CRYOKID)

Hepatitis C | Cryoglobulinaemic Glomerulonephritis
Zhongshan Hospital Xiamen University

Unknown

Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B (CHB)

Chronic Hepatitis b

China
Hospital Vall d'Hebron

Completed

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Hepatitis C Recurrence After Liver Transplant

Spain
Hoffmann-La Roche

Completed

Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection

HCV

Puerto Rico, United States
Kasr El Aini Hospital

Unknown

Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection

Parkinson Disease
Kawin Technology Share-holding Co., Ltd.
KawinGreen Biotech Co., Ltd.

Completed

Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C (KW-136_II)

Hepatitis C, Chronic

China
National Research Centre, Egypt
Egyptian Liver Hospital

Completed

Effect of Implementation Of Outreach Behavioral Change Program for HCV Elimination

Hepatitis C and B VIRUS Screening, Awareness and Behavior Assessment and Evaluation for All Inhabitants Above Twelve Years of Al Othmaneya Village
Changi General Hospital

Completed

Prevalence of IL28B Polymorphism in Hepatitis C Patients

Hepatitis C

Singapore
HepNet Study House, German Liverfoundation
Gilead Sciences; Hannover Medical School; Hoffmann-La Roche

Completed

HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis (HIDIT-II)

Hepatitis D

Germany, Greece, Romania
Mahidol University

Unknown

HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg

Chronic Hepatitis B, HBsAg, Hepatitis B Vaccine

Thailand
Roxane Laboratories

Completed

Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions

Breast Cancer

United States
Nanfang Hospital of Southern Medical University

Completed

A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China

Liver Injury | Liver Failure, Acute on Chronic
Icahn School of Medicine at Mount Sinai

Completed

Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood

Hepatitis C | HCV | Liver Transplant

United States
Ain Shams University

Unknown

Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients

Chronic Hepatitis c

Egypt
Blood Systems Research Institute

Completed

Improving Blood Safety and HIV Testing in Brazil

Hepatitis B | Hepatitis C | HIV | Chagas Disease | Herpes Simplex 2

Brazil
Novartis Pharmaceuticals

Terminated

3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study

Hepatitis C, Chronic

Romania, Italy, Germany, Belgium, Spain, Australia, Thailand, United States, Hungary, Taiwan, Poland, Canada, Puerto Rico, Vietnam, Korea, Republic of, India
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Humoral and Cellular Response in Shift Workers

Other Condition That May be a Focus of Clinical Attention

Brazil
Maastricht University Medical Center
Roche Pharma AG

Completed

Ribavirin, Its Dosing Regime (Ribados)

Hepatitis C

Netherlands
CHU de Reims

Completed

Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis (CALPRO-HAA)

Severe Alcoholic Hepatitis

France
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B

Chronic Hepatitis B

China
Egyptian Liver Hospital
Wadi El Nil Hospital

Completed

A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection

Hepatitis C

Egypt
AbbVie

Completed

A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Chronic Hepatitis C Infection

3

Subscribe